Skip to main content

Table 1 Baseline patient characteristics for all subjects and each HbA1c target group

From: Achievement of individualized treatment targets in patients with comorbid type-2 diabetes and hypertension: 6 months results of the DIALOGUE registry

Baseline characteristic

All subjects (n = 8,632*)

HbA1c ≤ 6.5% (n = 3,369)

HbA1c > 6.5% to ≤ 7.0% (n = 3,644)

HbA1c > 7.0% to ≤ 7.5% (n = 1,618)

P-values for the comparison of 3 groups

Age (years)

65.0 (57.0-74.0)

64.0 (55.0-73.0)

67.0 (59.0-74.0)

66.0 (58.0-75.0)

<0.0001

Age > 75 years (%)

19.7

17.7

20.5

22.0

<0.001

Female sex (%)

45.6

46.2

45.5

44.4

0.47

BMI (kg/m2)

31.2 ± 5.9

31.1 ± 5.9

31.3 ± 5.8

31.4 ± 6.0

0.38

BMI > 30 kg/m2 (%)

52.0

51.3

52.1

53.1

0.47

Waist circumference (cm)

107.6 ± 14.5

107.0 ± 15.0

108.0 ± 14.0

108.0 ± 14.7

0.50

Current smokers (%)

11.8

11.4

12.0

11.9

0.73

Diabetes duration (months)

67.9 (31.7-117.3)

55.7 (24.8-100.6)

75.1 (35.7-122.4)

82.7 (40.4-131.8)

<0.0001

Fasting glucose (mmol/l)

8.5 ± 2.8

7.8 ± 2.6

8.8 ± 2.6

9.7 ± 3.1

<0.0001

Postprandial glucose (mmol/l)

10.9 ± 3.4

10.0 ± 3.2

11.2 ± 3.3

12.1 ± 3.7

<0.0001

HbA1c (%)

7.8 ± 2.1

7.2 ± 1.3

8.0 ± 2.8

8.6 ± 1.5

<0.0001

 ≤6.5% (%)

14.7

28.9

7.1

2.0

<0.0001

 >6.5% to ≤ 7.0% (%)

17.4

25.6

16.2

2.5

<0.0001

 >7.0% to ≤ 7.5% (%)

19.8

17.7

23.1

16.8

<0.0001

SBP (mmHg)

140.3 ± 15.7

139.5 ± 15.9

140.7 ± 15.5

141.3 ± 15.6

<0.0001

DBP (mmHg)

82.6 ± 9.5

82.4 ± 9.8

82.7 ± 9.2

83.0 ± 9.4

<0.01

HR (beats/min)

75.0 ± 10.0

74.7 ± 10.4

75.0 ± 9.4

75.9 ± 10.5

<0.0001

  1. Legend: HbA1c, glycated hemoglobin; body mass index, BMI; SBP, systolic blood pressure; DBP, diastolic blood pressure; HR, heart rate; *for one patient no HbA1c target was indicated; data are provided as medians (interquartile range), percent or mean ± standard deviation.